Jazz Pharmaceuticals plcJAZZNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
108.38%
↑ 307% above average
Average (39q)
-52.48%
Historical baseline
Range
High:204.46%
Low:-1163.63%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 108.38% |
| Q2 2025 | -1128.07% |
| Q1 2025 | -129.30% |
| Q4 2024 | -26.69% |
| Q3 2024 | 30.47% |
| Q2 2024 | 201.24% |
| Q1 2024 | -45.95% |
| Q4 2023 | -28.94% |
| Q3 2023 | 9.36% |
| Q2 2023 | 25.05% |
| Q1 2023 | 147.86% |
| Q4 2022 | -1163.63% |
| Q3 2022 | -71.05% |
| Q2 2022 | -2.29% |
| Q1 2022 | 77.30% |
| Q4 2021 | 74.06% |
| Q3 2021 | 140.77% |
| Q2 2021 | -142.93% |
| Q1 2021 | -6.51% |
| Q4 2020 | -11.62% |
| Q3 2020 | -0.97% |
| Q2 2020 | 204.46% |
| Q1 2020 | -409.70% |
| Q4 2019 | -53.99% |
| Q3 2019 | -34.84% |
| Q2 2019 | 52.74% |
| Q1 2019 | -27.73% |
| Q4 2018 | -1.97% |
| Q3 2018 | 23.22% |
| Q2 2018 | 74.47% |
| Q1 2018 | -37.82% |
| Q4 2017 | 63.33% |
| Q3 2017 | -47.62% |
| Q2 2017 | 21.23% |
| Q1 2017 | -17.74% |
| Q4 2016 | 21.47% |
| Q3 2016 | -19.25% |
| Q2 2016 | 39.26% |
| Q1 2016 | 13.63% |
| Q4 2015 | -18.93% |